Hepatitis A and E among immigrants and refugees in Central Brazil

Rev Saude Publica. 2022 Apr 22:56:29. doi: 10.11606/s1518-8787.2022056003839. eCollection 2022.

Abstract

Objective: To estimate the prevalence of hepatitis A virus (HAV) and hepatitis E virus (HEV) among immigrants and refugees in Goiás, Central Brazil.

Methods: Overall, 355 individuals were interviewed, and blood samples were tested for anti-HAV and anti-HEV IgG. Anti-HEV-positive samples were similarly tested for HEV RNA.

Results: All participants were from Latin American countries, most of whom, young adult males. The overall anti-HAV IgG prevalence was 87.4% (95%CI: 83.5-90.4), of whom 94.9%, 75.6%, and 60% were from Haiti, Venezuela, and other Latin American countries, respectively (p < 0.001). Age above 19 years and more than 36 months residing in Brazil were associated with a higher prevalence of previous HAV and HEV infection, respectively. Of the children eligible for HAV vaccination according to the National Immunization Program, only eight (44%) had been vaccinated. The overall anti-HEV IgG prevalence was 6.5% (95%CI: 4.4-9.5). All anti-HEV IgG-positive individuals were Haitians, including a child born in Brazil. HEV RNA was detected in two of the anti-HEV IgG-positive samples.

Conclusion: The survey detected a high prevalence of anti-HAV and anti-HEV IgG among immigrants and refugees, and active HEV infection among some Haitian participants. Prevention measures are urgently required to interrupt enteric virus transmission in this emergent and vulnerable population.

MeSH terms

  • Adult
  • Brazil / epidemiology
  • Child
  • Emigrants and Immigrants*
  • Haiti
  • Hepatitis A Antibodies
  • Hepatitis A virus* / genetics
  • Hepatitis A* / epidemiology
  • Hepatitis Antibodies
  • Hepatitis E virus* / genetics
  • Hepatitis E* / epidemiology
  • Humans
  • Immunoglobulin G
  • Male
  • RNA
  • Refugees*
  • Young Adult

Substances

  • Hepatitis A Antibodies
  • Hepatitis Antibodies
  • Immunoglobulin G
  • RNA

Grants and funding

Funding: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq -Process 424313/2018-9). Fundação de Amparo à Pesquisa do Estado de Goiás (FAPEG/SES-GO - public call 04/2017).